Mirae Asset Global Etfs Holdings Ltd. Lyell Immunopharma, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 308,551 shares of LYEL stock, worth $228,327. This represents 0.0% of its overall portfolio holdings.
Number of Shares
308,551
Previous 271,996
13.44%
Holding current value
$228,327
Previous $375,000
47.47%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LYEL
# of Institutions
108Shares Held
171MCall Options Held
7.7KPut Options Held
15.3K-
Mwg Management Ltd. Washington, DC20.2MShares$14.9 Million17.35% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$11.2 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$11.2 Million14.08% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$9.99 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA11.9MShares$8.81 Million1.63% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $183M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...